BCAX R&D Expenses
Bicara Therapeutics Inc · R&D Expenses
BCAX R&D Expenses
Latest reported$132.08Mperiod ending
BCAX R&D Expenses ($31.31M → $132.08M)
Annual R&D Expenses
High-resolution chart · PNG
BCAX r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 125,096,000 | |
| 63,619,000 | |
| 30,617,000 | |
| 31,312,000 |